PharmaTech Solutions Inc (PTS), a subsidiary of Decision Diagnostics Corp, is a manufacturer and supplier of wholesale prescription drugs, home diagnostic and treatment products. The company offers blood glucose testing products to identify diabetes; and virion screening test system for screening coronavirus. It develops test strips to detect diabetes in cats, dogs, and horses. The company markets its products under GenUltimate, PetSure, and GenViro brands. PTS is headquartered in Westlake Village, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company PharmaTech Solutions Inc
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
PharmaTech Solutions Inc Company Overview
PharmaTech Solutions Inc Company Snapshot
PharmaTech Solutions Inc Pipeline Products and Ongoing Clinical Trials Overview
GenPrecis Precision Monitoring System Product Overview
GenSure Test Strip
GenSure Test Strip Product Overview
GenUltimate TBG - Version 2
GenUltimate TBG - Version 2 Product Overview
GenUltimate! TBG
GenUltimate! TBG Product Overview
GenUltimate! TBG - 100ct Test Strips
GenUltimate! TBG - 100ct Test Strips Product Overview
Genviro Confirmatory Test - COVID-19
Genviro Confirmatory Test - COVID-19 Product Overview
GenViro Saliva COVID-19 Swift Kit - Home Use
GenViro Saliva COVID-19 Swift Kit - Home Use Product Overview
GenViro Saliva COVID-19 Swift Kit - Professional Use
GenViro Saliva COVID-19 Swift Kit - Professional Use Product Overview
PharmaTech Solutions Inc - Key Competitors
PharmaTech Solutions Inc - Locations And Subsidiaries
Head Office
Recent Developments
PharmaTech Solutions Inc, Recent Developments
Dec 21, 2020: DECN to announce various testing results this week for its COVID-19 GenViro! Swift Kit
Dec 18, 2020: DECN comments on recent legal filings by Federal Agencies
Dec 16, 2020: DECN provides testing update for US, Korea and XPRIZE with plans for walk-in donor study for at-Home GenViro! Saliva Swift :10 Test Kit
Dec 10, 2020: DECN Secures exclusive distributor agreement with a German based company for the distribution of Genviro! Covid-19 :10 Saliva Testing kits and meters in 18 EU countries, Norway and the UK
Dec 01, 2020: DECN announces significant agreement with Russian Federation Partner for Genviro! and Genviro! Pro COVID-19 Testing Kits as well as its venerable GenUltimate! blood glucose products
Nov 23, 2020: DECN XPRIZE testing data for rapid COVID-19 testing technology yields near textbook results
Nov 12, 2020: DECN GenViro! trial using human saliva donors for its Swift Test Kits proceeds directly to FDA level testing as COVID-19 product testing enters “Home Stretch”
Nov 03, 2020: DECN announces additional distribution agreement with a distributor and dealers in Nigeria, Ivory Coast and Lebanon
Oct 19, 2020: DECN announces commencement of US-based donor study for FDA EUA guidance testing for their 10.5 second Genviro Saliva Swift COVID-19 Test Kits
Oct 13, 2020: DECN provides progress update on major events for its GenViro! Saliva swift kits for the detection of COVID-19